| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 单纯销售业务(元) | 211,184,192.90 | 545,788,325.35 | 292,426,378.38 | 500,944,423.74 | 301,112,248.71 |
| 集约化-IVD(元) | 350,825,045.46 | 719,478,808.40 | 365,075,154.88 | 1,041,207,005.73 | 520,912,447.70 |
| 集约化-SPD(元) | 413,678,327.13 | 740,867,201.24 | 353,363,177.93 | 688,852,488.34 | 327,877,013.44 |
| 新冠检测(元) | - | - | - | 77,627,737.51 | - |
| 营业成本(元) | |||||
| 单纯销售业务(元) | 160,710,425.36 | 398,784,629.93 | - | 374,347,625.96 | - |
| 集约化-IVD(元) | 258,446,107.82 | 547,146,049.57 | - | 798,152,017.69 | - |
| 集约化-SPD(元) | 370,390,524.32 | 667,511,793.53 | - | 620,268,101.70 | - |
| 新冠检测(元) | - | - | - | 57,300,269.68 | - |
| 毛利(元) | |||||
| 单纯销售业务(元) | 50,473,767.54 | 147,003,695.42 | - | 126,596,797.78 | - |
| 集约化-IVD(元) | 92,378,937.64 | 172,332,758.83 | - | 243,054,988.04 | - |
| 集约化-SPD(元) | 43,287,802.81 | 73,355,407.71 | - | 68,584,386.64 | - |
| 新冠检测(元) | - | - | - | 20,327,467.83 | - |
| 毛利率(%) | |||||
| 单纯销售业务(%) | 23.90 | 26.93 | - | 25.27 | - |
| 集约化-IVD(%) | 26.33 | 23.95 | - | 23.34 | - |
| 集约化-SPD(%) | 10.46 | 9.90 | - | 9.96 | - |
| 新冠检测(%) | - | - | - | 26.19 | - |
| 收入构成(%) | |||||
| 单纯销售业务(%) | 21.64 | 27.21 | 28.93 | 21.70 | 26.19 |
| 集约化-IVD(%) | 35.96 | 35.86 | 36.12 | 45.10 | 45.30 |
| 集约化-SPD(%) | 42.40 | 36.93 | 34.96 | 29.84 | 28.51 |
| 新冠检测(%) | - | - | - | 3.36 | - |
| 毛利构成(%) | |||||
| 单纯销售业务(%) | 27.12 | 37.43 | - | 27.61 | - |
| 集约化-IVD(%) | 49.63 | 43.88 | - | 53.00 | - |
| 集约化-SPD(%) | 23.26 | 18.68 | - | 14.96 | - |
| 新冠检测(%) | - | - | - | 4.43 | - |